2021 World Conference on Lung Cancer (Posters)-FP13. The Impact of the COVID-19 Pandemic on Lung Cancer Screening Programs in the United States

FP13. The Impact of the COVID-19 Pandemic on Lung Cancer Screening Programs in the United States

Video Transcription

Video Summary

The COVID-19 pandemic had a significant impact on lung cancer screening programs in the United States. A survey conducted between July and September 2020 found that 85% of programs experienced disruptions, with most going on hiatus for at least 5-10 weeks. Even after returning, there was a decrease in patient screening volume, particularly with new patients. Patient-based challenges, such as concerns about safety and financial barriers, were the primary obstacles in attracting patients back to healthcare facilities. The capacity of screening programs had recovered by the time of the survey, with an increase in the use of telemedicine. However, the decrease in screening volumes may lead to more late-stage lung cancer diagnoses in the future.

Asset Subtitle

Jennifer C. King

Meta Tag

Speaker Jennifer C. King

Topic Screening and Early Detection

Keywords

COVID-19 pandemic

lung cancer screening programs

disruptions

patient screening volume

patient-based challenges